These data mean that somatic inactivation of cdkn2a/b or rb1 did not show a synergic effect on tumor incidence rate or tumor types each other, and could be postulated that cdkn2a/b and rb1 have a distinct role in tumorigenesis. The gene discussed is RB1; the disease is neoplasm.